Literature DB >> 32515594

Copper-Catalyzed Stille Cross-Coupling Reaction and Application in the Synthesis of the Spliceostatin Core Structure.

Arun K Ghosh1, Joshua R Born1, Anne M Veitschegger1, Melissa S Jurica2.   

Abstract

An efficient palladium-free Stille cross-coupling reaction of allylic bromides and functionalized organostannylfuran using catalytic copper halide has been developed. The coupling reaction was optimized using CuI and low catalyst loading (down to 5 mol %). The reaction was conveniently carried out at ambient temperature in the presence of inorganic base to afford the coupling product in good-to-excellent yields. The utility of this reaction was demonstrated in the synthesis of a furan with sensitive functionalities. A sulfolene moiety was utilized as a masking group for the sensitive diene. Noyori asymmetric reduction, Achmatowicz reaction, and Kishi reduction steps converted sulfolene to a highly substituted tetrahydropyran intermediate used in the synthesis of the highly potent antitumor agents, spliceostatins, and their derivatives.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32515594      PMCID: PMC7900942          DOI: 10.1021/acs.joc.0c00976

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  25 in total

Review 1.  Expansion of the eukaryotic proteome by alternative splicing.

Authors:  Timothy W Nilsen; Brenton R Graveley
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

2.  Efficient synthesis of 3-sulfolenes from allylic alcohols and 1,3-dienes enabled by sodium metabisulfite as a sulfur dioxide equivalent.

Authors:  Hang T Dang; Vu T Nguyen; Viet D Nguyen; Hadi D Arman; Oleg V Larionov
Journal:  Org Biomol Chem       Date:  2018-05-15       Impact factor: 3.876

3.  Preparation of sigma- and pi-allylcopper(III) intermediates in SN2 and SN2' reactions of organocuprate(I) reagents with allylic substrates.

Authors:  Erika R Bartholomew; Steven H Bertz; Stephen Cope; Michael Murphy; Craig A Ogle
Journal:  J Am Chem Soc       Date:  2008-08-01       Impact factor: 15.419

4.  Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation.

Authors:  Gabriel A Roybal; Melissa S Jurica
Journal:  Nucleic Acids Res       Date:  2010-06-06       Impact factor: 16.971

Review 5.  Modulating splicing with small molecular inhibitors of the spliceosome.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Melissa S Jurica
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-07-21       Impact factor: 9.957

6.  Steroids and steroid analogues from Stille-Heck coupling sequences.

Authors:  Hans Wolf Sünnemann; Armin de Meijere
Journal:  Angew Chem Int Ed Engl       Date:  2004-02-06       Impact factor: 15.336

7.  Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.

Authors:  Qun Dang; Srinivas Rao Kasibhatla; K Raja Reddy; Tao Jiang; M Rami Reddy; Scott C Potter; James M Fujitaki; Paul D van Poelje; Jingwei Huang; William N Lipscomb; Mark D Erion
Journal:  J Am Chem Soc       Date:  2007-11-28       Impact factor: 15.419

8.  Enantioselective synthesis of spliceostatin E and evaluation of biological activity.

Authors:  Arun K Ghosh; Anne M Veitschegger; Venkata Reddy Sheri; Kerstin A Effenberger; Beth E Prichard; Melissa S Jurica
Journal:  Org Lett       Date:  2014-11-25       Impact factor: 6.005

9.  Enantioselective total syntheses of FR901464 and spliceostatin A and evaluation of splicing activity of key derivatives.

Authors:  Arun K Ghosh; Zhi-Hua Chen; Kerstin A Effenberger; Melissa S Jurica
Journal:  J Org Chem       Date:  2014-05-30       Impact factor: 4.354

10.  Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Beth E Prichard; Arun K Ghosh; Melissa S Jurica
Journal:  RNA       Date:  2016-01-07       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.